Market Research Report

A quick peek into the report

Product Definition

2.1 Scope of Work

3.1   Primary Research
3.2   Secondary Research
3.3   Data Sources and Categorization
3.4   Criteria for Company Profiles
3.5   Market Estimation and Forecast Methodology
3.6   Data Triangulation
3.7   Assumptions and Limitations

4.1   Industry Ecosystem
4.2   Regulatory Framework
4.2.1   North America
4.2.1.1   Regulatory Requirements in U.S.
4.2.1.2   Regulatory Requirements in Canada
4.2.2   Europe
4.2.3   Other Countries
4.3   Impact of COVID-19
4.3.1   Impact on Clinical Settings and Clinical Decision-Making
4.3.2   Impact on AI-Based Imaging Modality Manufacturers
4.3.3   Conclusion

5.1   Key Developments and Strategies
5.1.1   New Offerings
5.1.2   Partnerships, Alliances, and Business Expansions
5.1.3   Regulatory and Legal Approvals
5.1.4   Funding Activities
5.1.5   Mergers and Acquisitions
5.1.6   Procurement and Sales
5.2   Market Share Analysis
5.2.1   Market Share Analysis: Global AI-Enabled Imaging Modalities Market (Imaging Modality Providers)
5.3   Growth Share Analysis
5.3.1   Growth Share Matrix (by Modality)
5.3.2   Growth Share Matrix (by Workflow)
5.3.3   Growth Share Matrix (by Therapeutic Application)

6.1   Assumptions and Limitations
6.2   Global AI-Enabled Imaging Modalities Market Size and Forecast
6.3   Potential Opportunities – AI-Enabled Imaging Modalities
6.3.1   Standardization of Radiology Practice
6.3.2   Voluminous Medical Imaging Data Requiring Analysis
6.3.3   Decline in Imaging Reimbursement Forcing Facilities for Accelerated and Accurate Performance
6.3.4   Increasing Participation
6.4   Market Dynamics
6.4.1   Impact Analysis
6.4.1.1   Impact Analysis of Market Drivers and Market Restraints, 2019-2030
6.4.2   Market Drivers
6.4.2.1   Need for Personalized and Standardized Patient-Centric Care
6.4.2.2   Accurate and Rapid Diagnosis Enabled by Artificial Intelligence
6.4.2.3   Increasing Workload of Radiologists
6.4.2.4   Evolving Hardware Technologies and Data Quality
6.4.3   Market Restraints
6.4.3.1   Lag in Regulatory Approvals
6.4.3.2   Legal Implications of AI Systems
6.4.3.3   Rise in Medical Imaging Expenses
6.4.3.4   Data Security and Privacy Issues
6.4.3.5   Lack of Trained Staff
6.5   Key Vendors

7.1   Overview
7.2   Computed Tomography (CT)
7.3   Magnetic Resonance (MR)
7.4   Ultrasound
7.5   X-Ray
7.6   Positron Emission Tomography (PET)
7.7   Other Modalities

8.1   Overview
8.2   Image Acquisition
8.3   Image Analysis
8.4   Detection
8.5   Diagnosis and Treatment Decision Support
8.6   Predictive Analysis and Risk Assessment
8.7   Triage
8.8   Reporting and Communication

9.1   Overview
9.2   Cardiology
9.3   Oncology
9.3.1   Breast Cancer
9.3.2   Lung Cancer
9.3.3   Other cancer types
9.4   Neurology
9.5   Pulmonology
9.6   Others

10.1   Overview
10.2   North America
10.2.1   Market Footprint: North America AI-Enabled Imaging Modalities Market
10.2.2   North America AI-Enabled Imaging Modalities Market (by Country)
10.2.2.1   U.S.
10.2.2.2   Canada
10.3   Europe
10.3.1   Market Footprint: Europe AI-Enabled Imaging Modalities Market
10.3.2   Europe AI-Enabled Imaging Modalities Market (by Country)
10.3.2.1   U.K.
10.3.2.2   Germany
10.3.2.3   France
10.3.2.4   Spain
10.3.2.5   Italy
10.3.2.6   Rest-of-Europe
10.4   Asia-Pacific
10.4.1   Market Footprint: Asia-Pacific AI-Enabled Imaging Modalities Market
10.4.2   Asia-Pacific AI-Enabled Imaging Modalities Market (by Country)
10.4.2.1   China
10.4.2.2   Japan
10.4.2.3   Australia and New Zealand
10.4.2.4   South Korea
10.4.2.5   Singapore
10.4.2.6   Rest-of-Asia-Pacific
10.5   Rest-of-the-World (RoW)
10.5.1   Market Footprint: Rest-of-the-World AI-Enabled Imaging Modalities Market

11.1   Overview
11.2   Agfa-Gevaert Group
11.2.1   Company Overview
11.2.2   Role of Agfa-Gevaert Group in the Global AI-Enabled Imaging Modalities Market
11.2.3   Financials
11.2.4   Agfa-Gevaert Group: SWOT Analysis
11.3   Butterfly Network, Inc.
11.3.1   Company Overview
11.3.2   Role of Butterfly Network, Inc. in the Global AI-Enabled Imaging Modalities Market
11.3.3   Butterfly Network, Inc.: SWOT Analysis
11.4   Canon, Inc.
11.4.1   Company Overview
11.4.2   Role of Canon, Inc. in the Global AI-Enabled Imaging Modalities Market
11.4.3   Financials
11.4.4   Canon, Inc.: SWOT Analysis
11.5   Exo
11.5.1   Company Overview
11.5.2   Role of Exo in the Global AI-Enabled Imaging Modalities Market
11.5.3   Exo: SWOT Analysis
11.6   Fujifilm Holdings Corporation
11.6.1   Company Overview
11.6.2   Role of Fujifilm Holdings Corporation in the Global AI-Enabled Imaging Modalities Market
11.6.3   Financials
11.6.3.1   Key Insights About the Financial Health of the Company
11.6.4   Fujifilm Holdings Corporation: SWOT Analysis
11.7   General Electric Company
11.7.1   Company Overview
11.7.2   Role of General Electric Company in the Global AI-Enabled Imaging Modalities Market
11.7.3   Financials
11.7.3.1   Key Insights About the Financial Health of the Company
11.7.4   General Electric Company: SWOT Analysis
11.8   Hyperfine
11.8.1   Company Overview
11.8.2   Role of Hyperfine in the Global AI-Enabled Imaging Modalities Market
11.8.3   Hyperfine: SWOT Analysis
11.9   Hologic, Inc.
11.9.1   Company Overview
11.9.2   Role of Hologic, Inc. in the Global AI-Enabled Imaging Modalities Market
11.9.3   Financials
11.9.4   Hologic, Inc.: SWOT Analysis
11.10 Konica Minolta, Inc.
11.10.1   Company Overview
11.10.2   Role of Konica Minolta, Inc. in the Global AI-Enabled Imaging Modalities Market
11.10.3   Financials
11.10.4   Konica Minolta, Inc.: SWOT Analysis
11.11   Koninklije Philips N.V.
11.11.1   Company Overview
11.11.2   Role of Koninklijke Philips N.V. in the Global AI-Enabled Imaging Modalities Market
11.11.3   Financials
11.11.3.1   Key Insights About the Financial Health of the Company
11.11.4   Koninklijke Philips N.V.: SWOT Analysis
11.12   Nanox
11.12.1   Company Overview
11.12.2   Role of Nanox in the Global AI-Enabled Imaging Modalities Market
11.12.3   SWOT Analysis: Nanox
11.13   Siemens Healthineers AG
11.13.1   Company Overview
11.13.2   Role of Siemens Healthineers AG in the Global AI-Enabled Imaging Modalities Market
11.13.3   Financials
11.13.3.1   Key Insights About the Financial Health of the Company
11.13.4   Siemens Healthineers AG: SWOT Analysis
11.14   Tissue Differentiation Intelligence, LLC (TDi)
11.14.1   Company Overview
11.14.2   Role of Tissue Differentiation Intelligence, LLC (TDi) in the Global AI-Enabled Imaging Modalities Market
11.14.3   SWOT Analysis: Tissue Differentiation Intelligence, LLC (TDi)
11.15   United Imaging Healthcare
11.15.1   Company Overview
11.15.2   Role of United Imaging Healthcare in the Global AI-Enabled Imaging Modalities Market
11.15.3   United Imaging Healthcare: SWOT Analysis
11.16   Yor Labs, Inc.
11.16.1   Company Overview
11.16.2   Role of Yor Labs, Inc. in the Global AI-Enabled Imaging Modalities Market
11.16.3   Yor Labs, Inc.: SWOT Analysis

Table 1:   Impact Analysis of Market Drivers
Table 2:   Impact Analysis of Market Restraints
Table 6.1:   Impact Analysis of Market Drivers
Table 6.2:   Impact Analysis of Market Restraints

Figure 1:   Applications of AI in Healthcare
Figure 2:   Share of Key Developments and Strategies, February 2016 - July 2020
Figure 3:   Imaging Modality Providers Leading Global AI-Enabled Imaging Modalities Market, 2020
Figure 4:   Global AI-Enabled Imaging Modalities Market, 2019-2030
Figure 5:   Global AI-Enabled Imaging Modalities Market Share (by Workflow), 2019 and 2030
Figure 6:   Global AI-Enabled Imaging Modalities Market Share (by Therapeutic Application), 2019 and 2030
Figure 7:   Global AI-Enabled Imaging Modalities Market Share (by Modality), 2019 and 2030
Figure 8:   Global AI-Enabled Imaging Modalities Market Regional Snapshot
Figure 2.1: Global AI-Enabled Imaging Modalities Market Segmentation
Figure 3.1:   Research Methodology
Figure 3.2:   Primary Research Methodology
Figure 3.3:   Secondary Research
Figure 3.4:   Data Triangulation
Figure 3.5:   Assumptions and Limitations
Figure 4.1:   Industry Ecosystem
Figure 5.1:   Share of Key Developments and Strategies, February 2016-July 2020
Figure 5.2:   Share of New Offerings, February 2016–July 2020
Figure 5.3:   Share of Partnerships, Alliances & Business Expansions, February 2016- July 2020
Figure 5.4:   Share of Regulatory & Legal Approvals, February 2016–July 2020
Figure 5.5:   Share of Funding Activities, February 2016–July 2020
Figure 5.6:   Share of Mergers & Acquisition, February 2016–July 2020
Figure 5.7:   Market Share Analysis: Global AI-Enabled Imaging Modalities Market (Imaging Modality Providers), 2020
Figure 5.8:   Market Share Analysis: Global AI-Enabled Imaging Modalities Market (by Imaging Modality Provider), 2019
Figure 5.9:   Growth Share Matrix: Global AI-Enabled Imaging Modalities Market (by Modality), 2019-2030
Figure 5.10:   Growth Share Matrix: Global AI-Enabled Imaging Modalities Market (by Workflow), 2019-2030
Figure 5.11:   Growth Share Matrix: Global AI-Enabled Imaging Modalities Market (by Therapeutic Application), 2019-2030
Figure 6.1:   Global AI-Enabled Imaging Modalities Market, 2019-2030
Figure 7.1:   Global AI-Enabled Imaging Modalities Market (by Modality), 2019-2030
Figure 7.2:   Global AI-Enabled Imaging Modalities Market (by CT), 2019-2030
Figure 7.3:   Global AI-Enabled Imaging Modalities Market (by Magnetic Resonance), 2019-2030
Figure 7.4:   Global AI-Enabled Imaging Modalities Market (by Ultrasound), 2019-2030
Figure 7.5:   Global AI-Enabled Imaging Modalities Market (by X-Ray), 2019-2030
Figure 7.6:   Global AI-Enabled Imaging Modalities Market (by Positron Emission Tomography (PET)), 2019-2030
Figure 7.7:   Global AI-Enabled Imaging Modalities Market (by Other Modalities), 2019-2030
Figure 8.1:   Global AI-Enabled Imaging Modalities Market (Image Acquisition), 2019-2030
Figure 8.2:   Global AI-Enabled Imaging Modalities Market (Image Analysis), 2019-2030
Figure 8.3:   Global AI-Enabled Imaging Modalities Market (Detection), 2019-2030
Figure 8.4:   Global AI-Enabled Imaging Modalities Market (Diagnosis and Treatment Decision Support), 2019-2030
Figure 8.5:   Global AI-Enabled Imaging Modalities Market (Predictive Analysis and Risk Assessment), 2019-2030
Figure 8.6:   Global AI-Enabled Imaging Modalities Market (Triage), 2019-2030
Figure 8.7:   Global AI-Enabled Imaging Modalities Market (Reporting and Communication), 2019-2030
Figure 9.1:   Global AI-Enabled Imaging Modalities Market (by Therapeutic Application), 2019 and 2030
Figure 9.2:   Global AI-Enabled Imaging Modalities Market (Cardiology), 2019-2030
Figure 9.3:   Applications of AI in Cancer Imaging
Figure 9.4:   Global AI-Enabled Imaging Modalities Market (Oncology), 2019-2030
Figure 9.5:   Global AI-Enabled Imaging Modalities Market (Neurology), 2019-2030
Figure 9.6:   Global AI-Enabled Imaging Modalities Market (Pulmonology), 2019-2030
Figure 9.7:   Global AI-Enabled Imaging Modalities Market (Others), 2019-2030
Figure 10.1:   Global AI-Enabled Imaging Modalities Market Scenario, 2019 and 2030
Figure 10.2:   North America AI-Enabled Imaging Modalities Market, 2019-2030
Figure 10.3:   North America AI-Enabled Imaging Modalities Market: Market Dynamics
Figure 10.4:   North America AI-Enabled Imaging Modalities Market (by Country), 2019-2030
Figure 10.5:   U.S. AI-Enabled Imaging Modalities Market, 2019-2030
Figure 10.6:   Canada AI-Enabled Imaging Modalities Market, 2019-2030
Figure 10.7:   Europe AI-Enabled Imaging Modalities Market, 2019-2030
Figure 10.8:   Europe AI-Enabled Imaging Modalities Market: Market Dynamics
Figure 10.9:   Europe AI-Enabled Imaging Modalities Market (by Country), 2019-2030
Figure 10.10:   U.K. AI-Enabled Imaging Modalities Market, 2019-2030
Figure 10.11:   Germany AI-Enabled Imaging Modalities Market, 2019-2030
Figure 10.12:   France AI-Enabled Imaging Modalities Market, 2019-2030
Figure 10.13:   Spain AI-Enabled Imaging Modalities Market, 2019-2030
Figure 10.14:   Italy AI-Enabled Imaging Modalities Market, 2019-2030
Figure 10.15:   Rest-of-Europe AI-Enabled Imaging Modalities Market, 2019-2030
Figure 10.16:   Asia-Pacific AI-Enabled Imaging Modalities Market, 2019-2030
Figure 10.17:   Asia-Pacific AI-Enabled Imaging Modalities Market: Market Dynamics
Figure 10.18:   Asia-Pacific AI-Enabled Imaging Modalities Market (by Country), 2019-2030
Figure 10.19:   China AI-Enabled Imaging Modalities Market, 2019-2030
Figure 10.20:   Japan AI-Enabled Imaging Modalities Market, 2019-2030
Figure 10.21:   Australia and New Zealand AI-Enabled Imaging Modalities Market, 2019-2030
Figure 10.22:   South Korea AI-Enabled Imaging Modalities Market, 2019-2030
Figure 10.23:   Singapore AI-Enabled Imaging Modalities Market, 2019-2030
Figure 10.24:   Rest-of-Asia-Pacific AI-Enabled Imaging Modalities Market, 2019-2030
Figure 10.25:   Rest-of-the-World AI-Enabled Imaging Modalities Market, 2019-2030
Figure 11.1:   Shares of Key Company Profiles
Figure 11.2:   Agfa-Gevaert Group: Product Offerings for the Global AI-Enabled Imaging Modalities Market
Figure 11.3:   Agfa-Gevaert Group: Overall Financials ($Billion), 2017-2019
Figure 11.4:   Agfa-Gevaert Group: Net Revenue (by Business Segment), $Billion, 2017-2019
Figure 11.5:   Agfa-Gevaert Group: Revenue (by Region), $Billion, 2017-2019
Figure 11.6:   Agfa-Gevaert Group: R&D Expenditure, 2017-2019
Figure 11.7:   Butterfly Network, Inc.: Product Offerings for the Global AI-Enabled Imaging Modalities Market
Figure 11.8:   Canon, Inc.: Product Offerings for the AI-Enabled Imaging Modalities Market
Figure 11.9:   Canon, Inc.: Overall Financials ($Billion), 2017-2019
Figure 11.10:   Canon, Inc.: Net Revenue (by Business Segment), $Billion, 2017-2019
Figure 11.11:   Canon, Inc.: Revenue (by Region), $Billion, 2017-2019
Figure 11.12:   Canon, Inc.: R&D Expenditure, 2017-2019
Figure 11.13:   Exo: Product Offerings for the Global AI-Enabled Imaging Modalities Market
Figure 11.14:   Fujifilm Holdings Corporation: Product Offerings for the Global AI-Enabled Imaging Modalities Market
Figure 11.15:   Fujifilm Holdings Corporation: Overall Financials, 2017-2019
Figure 11.16:   Fujifilm Holdings Corporation Net Revenue (by Business Segment), 2017-2019
Figure 11.17:   Fujifilm Holdings Corporation: Net Revenue (by Region), 2016-2018
Figure 11.18:   Fujifilm Holdings Corporation: R&D Expense, 2016-2018
Figure 11.19:   General Electric Company: Product Offerings for the Global AI-Enabled Imaging Modalities Market
Figure 11.20:   General Electric Company: Overall Financials, 2017-2019
Figure 11.21:   General Electric Company Net Revenue (by Business Segment), 2017-2019
Figure 11.22:   General Electric Company: Net Revenue (by Region), 2017-2019
Figure 11.23:   General Electric Company: R&D Expenditure, 2017-2019
Figure 11.24:   Hyperfine: Product Offerings for the AI-Enabled Imaging Modalities Market
Figure 11.25:   Hologic, Inc.: Product Offerings for the AI-Enabled Imaging Modalities Market
Figure 11.26:   Hologic, Inc.: Overall Financials ($Billion), 2017-2019
Figure 11.27:   Hologic, Inc.: Net Revenue (by Business Segment), $Billion, 2017-2019
Figure 11.28:   Hologic, Inc.: Revenue (by Region), $Billion, 2017-2019
Figure 11.29:   Hologic, Inc.: R&D Expenditure, 2017-2019
Figure 11.30:   Konica Minolta, Inc.: Product Offerings for the Global AI-Enabled Imaging Modalities Market
Figure 11.31:   Konica Minolta, Inc.: Overall Financials ($Billion), 2017-2019
Figure 11.32:   Konica Minolta, Inc.: Net Revenue (by Business Segment), $Billion, 2017-2019
Figure 11.33:   Konica Minolta, Inc.: Revenue (by Region), $Billion, 2017-2019
Figure 11.34:   Konica Minolta, Inc.: R&D Expenditure, 2017-2019
Figure 11.35:   Koninklijke Philips N.V.: Product Offerings for the Global AI-Enabled Imaging Modalities Market
Figure 11.36:   Koninklijke Philips N.V.: Overall Financials, 2017-2019
Figure 11.37:   Koninklijke Philips N.V. Net Revenue (by Business Segment), 2017-2019
Figure 11.38:   Koninklijke Philips N.V.: Net Revenue (by Region), 2017-2019
Figure 11.39:   Koninklijke Philips N.V.: R&D Expenditure, 2017-2019
Figure 11.40:   Nanox: Product Offerings for the Global AI-Enabled Imaging Modalities Market
Figure 11.41:   Siemens Healthineers AG: Product Offerings for the Global AI-Enabled Imaging Modalities Market
Figure 11.42:   Siemens Healthineers AG: Overall Financials, 2017-2019
Figure 11.43:   Siemens Healthineers AG Net Revenue (by Business Segment), 2017-2019
Figure 11.44:   Siemens Healthineers AG: Net Revenue (by Region), 2017-2019
Figure 11.45:   Siemens Healthineers AG: R&D Expenditure, 2017-2019
Figure 11.46:   Tissue Differentiation Intelligence, LLC: Product Offerings for the Global AI-Enabled Imaging Modalities Market
Figure 11.47:   United Imaging Healthcare: Product Offerings for the Global AI-Enabled Imaging Modalities Market
Figure 11.48:   Yor Labs, Inc.: Product Offerings for the Global AI-Enabled Imaging Modalities Market

Report Description

Market Report Coverage - Global AI-Enabled Imaging Modalities
Base Year	2019	Market Size in 2019	$214.4 Million
Forecast Period	2020-2030	Value Projection and Estimation by 2030	$2,649.6 Million
CAGR During Forecast Period	23.32%	Number of Tables	4
Number of Pages	208	Number of Figures	121
Research Hours	190
Market Segmentation	• Therapeutic Application – Cardiology, Oncology (Breast, Lung, Other Cancer Types), Neurology, Pulmonology, and Others • Modality- CT, MRI, X-Ray, Ultrasound, PET, Other Modalities • Workflow- Image Acquisition, Image Analysis, Detection, Diagnosis, and Treatment Decision Support, Predictive Analysis & Risk Assessment, Triage, Reporting and Communication
Regional Segmentation	• North America- U.S. and Canada • Europe- Germany, U.K, Italy, Spain, France, and Rest-of-Europe • Asia-Pacific- Japan, China, South Korea, Australia, Singapore and Rest-of-Asia-Pacific • Rest-of-the-World
Growth Drivers	• Need for Personalized and Standardized Patient-centric Care • Accurate and Speed Diagnosis • Increasing Radiologist Workload • Evolving Hardware Technologies and Data Quality Acquired
Market Challenges	• Legal Implications of AI systems • Stringent Regulatory Requirements • Rise in Medical Imaging Expenses • Data Security and Privacy Issues
Market Opportunities	• Standardization of Radiology Practice • Voluminous Medical Imaging Data • Decline in Imaging Reimbursement • Increasing Participation
Key Companies Profiled	Koninklijke Philips N.V., Siemens Healthineers AG., General Electric Company, Canon, Inc., Agfa, Hologic, Fujifilm, and Konica Minolta, Inc., United Health Imaging, Exo, Yorlabs, Nanox, TDI, Butterfly Network, Inc., and Hyperfine.

Key Questions Answered in this Report:

•   What are the various AI-enabled imaging modalities and systems available in the market?
•   What is the current market size and future potential of these products?
•   What are the major market drivers, challenges, and opportunities in the global AI-enabled imaging modalities market?
•   What are the guidelines implemented by different government bodies to regulate the approval of AI-enabled imaging modalities?
•   What are the key technological developments on which the current industry leaders are spending a major share of their research and development (R&D) investments?
•   Who are the leading players holding dominating shares in the global AI-enabled imaging modalities market, currently?
•   What are the key strategies incorporated by the players of global AI-enabled imaging modalities market, to sustain the competition and retain their supremacy?
•   What is the current revenue contribution of different modality types and how are these contributions expected to evolve in the forecast period?
•   What is the current revenue contribution of different therapeutic applications and how are these contributions expected to be evolved in the forecast period?
•   What is the current demand contributions of different workflow types and how are these contributions expected to evolve in the forecast period?
•   Which countries contribute to the major share of current demand and which countries hold significant scope for expansion for business activities, by players of the global AI-enabled imaging modalities market?

Market Overview

Overview on the Global AI-Enabled Imaging Modalities Market

Global AI-enabled imaging modalities market is currently witnessing a significant change in the market landscape. There is rising investment in development of healthcare infrastructure, increasing evidences for efficient and promising results in treatment and diagnosis assistance. Thus, this is leading to potential growth opportunities for the AI-enabled imaging modalities market. Moreover, there is an extensive entry of emerging players developing AI powered imaging systems, and software companies into the healthcare space. All these predominant factors have led to a significant rise in sales of AI-based imaging modality systems across the globe.

Global AI-Enabled Imaging Modalities Market Forecast, 2020-2030

The global AI-enabled imaging modalities market was valued at $214.4 million in 2019 and is anticipated to reach $2,649.6 million by 2030, growing at a CAGR of 23.32%, during the forecast period 2020-2030. The increasing complexities in clinical decision making, rising radiologist workload, and huge R&D investments are the major factors fueling the market growth. In addition to these factors, there are significant challenges and restraints, which are restricting the market growth. These challenges include the physicians’ reluctance toward the adoption of advanced technologies such as AI and the privacy and security concerns related to healthcare data. Hence, it is anticipated that these trends will have a significant impact on healthcare service robots market in the next five years, and the market will grow multifold.

Competitive Landscape

The global AI-enabled imaging modalities market consists of numerous large-scale as well as small-scale manufacturers and vendors. Presently, with the increasing adoption of AI in healthcare, the manufacturers in the market have ample number of opportunities to expand their offerings and to establish a strong foothold in the market.

During February 2016-July 2020, the market witnessed approximately 40 new offerings, 32 partnerships, alliances & business expansions, 27 regulatory & legal approvals, 13 funding activities, six mergers & acquisition, and one procurement & sales.

Most of the manufacturers in the market are incorporating collaborations and partnerships with not only other companies but also the university and research institutions as the key strategies to develop novel AI-embedded medical imaging systems and attain a strong financial position in the market.

The key players contributing to the global AI-enabled Imaging modalities market are Koninklijke Philips N.V., Siemens Healthineers AG., General Electric Company, Canon, Inc., Butterfly Network, Inc., Hyperfine, United Imaging Healthcare, Exo, Yorlabs, Agfa-Gevaert Group, Hologic, Inc, Fujifilm, Konica Minolta, Inc., Nanox, and Tissue Differentiation Imaging (TDI), among others.